Earnings Feed
Start Free
Sage Therapeutics, Inc.·4

Mar 17, 4:09 PM ET

IGUCHI KIMI 4

4 · Sage Therapeutics, Inc. · Filed Mar 17, 2023

Insider Transaction Report

Form 4
Period: 2023-03-15
Sage Therapeutics, Inc.SAGE
IGUCHI KIMI
See Remarks
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-15$1.36/sh+3,000$4,080→ 65,560 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-03-15−3,000→ 1,642 total
    Exercise: $1.36Exp: 2024-01-22→ Common Stock (3,000 underlying)
Footnotes (1)
  • [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.

Documents

2 files